Sluiten Added to My program.
Sluiten Removed from My program.
Back Home

Bootcongres

Wed, March 26th, 2014, 14:30 - 14:40

Blocking follicular T-helper cell driven B-cell stimulation by the IL-21-receptor antagonist is a novel therapeutic option in kidney-transplant patients

G.N. de Graav, M. Dieterich, D.A. Hesselink, K. Boer, M. Clahsen, R. Kraaijeveld, N. Litjens, J. Vanderlocht, M.G.J. Tilanus, D.L. Roelen, F.H.J. Claas, M.G.H. Betjes, W. Weimar, C.C. Baan

Moderator(s): F.J. Bemelman en J.W. de Fijter

Location(s): Grote zaal

Category:

Background: Understanding and defining the process of injury to the transplanted kidney is essential for improving short and long term allograft survival. In this process B cells are harmful through the generation of donor-specific alloantibody. Important cells that stimulate differentiation of B-lymphocytes into harmful immunoglobulin-producing plasmablasts (through IL-21) are follicular T-helper (TFH) cells. We studied the function of peripheral TFH-cells in patients before and after kidney-transplantation (KT) in vitro and in vivo. Methods: Numbers of plasmablasts and TFH-cells (CD4+CXCR5+ T-cells) including their IL-21 production were measured before and after KT (n=30), as well as DSA (positive when MFI≥4000). Function was studied by co-culture experiments of TFH-cells with endotoxin-activated B-cells (CD4+CXCR5- T-cells as negative control). After 7 days of co-culture, we measured B-cell differentiation into plasmablasts and immunoglobulin(Ig)-production. To define the role of IL-21 , the IL-21-receptor was blocked. Finally, by immunehistochemistry the presence of TFH-cells was established in rejection biopsies. Results: While the numbers of TFH-cells remained stable after KT, the numbers of plasmablasts were reduced after KT (p<0.01). However, after KT TFH-cells were three times higher in patients with pre-existing DSA than in patients without pre-existent DSA (p<0.02). Moreover, the IL-21 production capacity by TFH-cells decreased after KTx in patients without pre-existing DSA (p<0.01), but not in patients with DSA. In vitro, TFH-cells induced B-cell differentiation into Ig-producing plasmablasts (p<0.05). TFH-cells obtained after KT were still able to stimulate B-cell differentiation and Ig-production (p<0.05). Blocking the IL-21-R suppressed these processes (p<0.05). Follicular-like structures were observed in the biopsies of the transplants with type I cellular rejections, which showed the presence of T-cells expressing the transcription factor for TFH-cells, BCL-6. Moreover, these type I cellular biopsies stained positive for Ig. 

Conclusions: In KT-patients the differentiation of B cells into Ig-producing plasmablasts depends on IL-21 producing TFH-cells. Inhibition of the IL-21 pathway could be a novel approach for the treatment of humoral responses after KT and might improve allograft survival in patients with pre-existing DSA.